Physician
Adirondack Interventional Physiatry PC
Adirondack Interventional Physiatry PC was paid $1.45M by Medicaid between Jan 2018 and Nov 2024, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 54% of everything it billed.
33Billing provider infoADIRONDACK INTERVENTIONAL PHYSIATRY PC
PLATTSBURGH, NY 12901
PLATTSBURGH, NY 12901
33aNPI1821166166assigned 12/04/2006
33bProvider typeInterventional Pain Medicine Physician
28Total paid$1.45M
24GClaims26,757
24DCodes billed45
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Interventional Pain Medicine Physician providers in New York
Rank by total paid#4 of 58
Median peer was paid$24K
This provider vs. median59×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,128 | $315K | |
| 2019 | 10,317 | $276K | |
| 2020 | 3,557 | $191K | |
| 2021 | 2,454 | $220K | |
| 2022 | 2,129 | $217K | |
| 2023 | 1,473 | $152K | |
| 2024incomplete | 699 | $80K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 54% | 9,365 | 9,079 | $789K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 3,320 | 3,268 | $386K |
| 64493 | 4.6% | 278 | 277 | $66K | |
| 64494 | 2.2% | 264 | 263 | $32K | |
| 99152 | 2.2% | 566 | 539 | $32K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 1.9% | 2,218 | 2,116 | $28K |
| 64495 | 1.6% | 171 | 171 | $23K | |
| 62323 | 1.2% | 79 | 76 | $18K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 488 | 453 | $13K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 53 | 53 | $9K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 70 | 70 | $9K |
| 64635 | <1% | 25 | 25 | $7K |
33 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 581 | $6K |
| 98967 | <1% | 123 | $4K | |
| 64490 | <1% | 13 | $4K | |
| 80353 | <1% | 564 | $3K | |
| 80356 | <1% | 564 | $3K | |
| 64636 | <1% | 25 | $2K | |
| 98966 | <1% | 114 | $2K | |
| A4209 | Syringe with needle, sterile 5 cc or greater, each | <1% | 1,503 | $2K |
| 76942 | <1% | 15 | $1K | |
| 77002 | <1% | 29 | $1K | |
| 80348 | <1% | 466 | $970.14 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14 | $748.30 |
| 80359 | <1% | 466 | $747.81 | |
| 80365 | <1% | 466 | $742.81 | |
| 80361 | <1% | 466 | $742.81 | |
| 80346 | <1% | 465 | $742.81 | |
| 80324 | <1% | 466 | $742.81 | |
| 80358 | <1% | 466 | $742.81 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,907 | $666.78 |
| 80349 | <1% | 466 | $585.00 | |
| 80345 | <1% | 466 | $585.00 | |
| 99441 | <1% | 13 | $564.23 | |
| 83992 | <1% | 12 | $270.82 | |
| 80373 | <1% | 12 | $151.25 | |
| 80354 | <1% | 12 | $151.25 | |
| 80355 | <1% | 12 | $151.25 | |
| 80366 | <1% | 12 | $151.25 | |
| 80360 | <1% | 12 | $151.25 | |
| 80368 | <1% | 12 | $110.00 | |
| 80370 | <1% | 12 | $96.25 | |
| 80321 | <1% | 12 | $77.00 | |
| 80333 | <1% | 12 | $57.75 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 82 | $14.91 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBONNABESSE, THIERRY (OWNER/PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Champlain Toxicology Lab, LLC | Plattsburgh, NY | $269K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.